Immunocore Holdings plc

IMCR ·Healthcare, Drug Manufacturers - General, United Kingdom
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Nov 9, 2026
10-Q Nov 6, 2026 10-Q
8-K Nov 6, 2026 8-K
SCHEDULE 13G/A Oct 7, 2026
8-K Sep 14, 2026 8-K
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
SCHEDULE 13G/A Aug 6, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 May 28, 2026
4 May 28, 2026
4 May 28, 2026
4 May 28, 2026
4 May 28, 2026
4 May 28, 2026
8-K May 27, 2026 8-K
144 May 22, 2026
144 May 21, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
S-8 May 8, 2026 S-8
8-K May 6, 2026 8-K
10-Q May 6, 2026 10-Q
ARS Apr 16, 2026 ARS
← Newer Page 1 of 12 · 282 filings Older →